Akut mieloid leukémia (AML): vizsgálatok itt: Belgium
27 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
- Where
- Edegem, Gent, Leuven
- People
- 225 worldwide
- Run by
- Janssen Cilag International
See details and how to join2026-525234-39-00 · EU 2026-525234-39-00 - 3. fázisTaking peopleBleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
- Where
- Anderlecht, Antwerp, Brugge, Charleroi, Edegem, Geel, Gent, Hasselt, La Louvière, Leuven, Liège, Sint-Lambrechts-Woluwe, Yvoir
- Életkor
- 18 év and over
- People
- 875 worldwide
- Run by
- Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT07223814 · EU 2025-522767-15-00 - 1. fázisCsak meghívásosA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Gent
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 3. fázisTaking peoplePhase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
- Where
- Antwerp, Brugge, Brussel, Leuven, Roeselare, Yvoir
- Életkor
- 18 év to 75 év
- People
- 650 worldwide
- Run by
- University of Ulm
See details and how to joinNCT04628026 · EU 2023-507518-28-00 - 3. fázisTaking peopleA Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Where
- Bruges, Edegem, Genk, Ghent, La Louvière, Leuven, Ottignies, Roeselare
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06852222 · EU 2024-520154-38-00 - 3. fázisTaking peopleA study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia (AML) with a specific gene abnormality who have not previously been treated and who are not eligible for intensive chemotherapy.
- Where
- Anderlecht, Antwerp, Gent, Jette, Leuven, Liège, Sint-Lambrechts-Woluwe, Yvoir
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
See details and how to join2024-512753-24-00 · EU 2024-512753-24-00 - 3. fázisTaking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Gent
- Életkor
- 12 év and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - 3. fázisTaking peopleTeicoplanin as Infection Prophylaxis in Pediatric Acute Myeloid Leukemia (Pro-Teico study)
- Where
- Gent, Leuven
- Életkor
- Up to 64 év
- People
- 128 worldwide
- Run by
- Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-506546-23-00 · EU 2023-506546-23-00 - 3. fázisTaking peopleStudies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Where
- Brugge, Gent, Jette, Liège, Roeselare, Verviers
- Életkor
- 18 év and over
- People
- 1300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT07007312 · EU 2025-521314-25-00 - 1/2. fázisTaking peopleSafety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
- Where
- Ghent
- Életkor
- 1 év to 17 év
- People
- 70 worldwide
- Run by
- Incyte Biosciences International Sàrl
See details and how to joinNCT03934372 · EU 2023-509699-41-00 - 3. fázisTaking peopleCHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)
- Where
- Brussels, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Életkor
- Up to 64 év
- People
- 675 worldwide
- Run by
- Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-504999-25-00 · EU 2023-504999-25-00 - 2. fázisTaking people(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Liège
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - 3. fázisTaking peopleRevumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
- Where
- Anderlecht, Antwerp, Brugge, Gent, Jette, Leuven, Liège, Sint-Lambrechts-Woluwe, Yvoir
- Életkor
- 18 év and over
- People
- 448 worldwide
- Run by
- Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT06652438 · EU 2024-512733-32-00 - 2/3. fázisTaking peopleL-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
- Where
- Anderlecht
- Életkor
- 18 év to 80 év
- People
- 312 worldwide
- Run by
- Moleculin Biotech, Inc.
See details and how to joinNCT06788756 · EU 2024-518359-47-00 - 1. fázisTaking peopleA Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Where
- Gent
- Életkor
- Up to 17 év
- People
- 18 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2024-520125-36-00 · EU 2024-520125-36-00 - 3. fázisTaking peopleStudy comparing thymoglobulin to grafalon, two treatments used to prevent graft versus host disease in elderly patients with acute myeloid leukemia or myelodysplastic syndrome and receiving an allogeneic stem cell transplantation with an unrelated matched donor after a reduced intensity conditioning regimen
- Where
- Sint-Lambrechts-Woluwe
- Életkor
- 18 év and over
- People
- 334 worldwide
- Run by
- Assistance Publique Hopitaux De Paris
See details and how to join2023-504555-27-00 · EU 2023-504555-27-00 - 3. fázisTaking peopleAn Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
- Where
- Antwerp, Brugge, Hasselt, Liège, Roeselare, Yvoir
- Életkor
- 18 év and over
- People
- 245 worldwide
- Run by
- Servier Affaires Médicales
See details and how to joinNCT05907057 · EU 2022-501709-11-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Antwerp, Ghent, Leuven, Roeselare
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - 4. fázisTaking peoplePTX3-targeted Antifungal Prophylaxis
- Where
- Gent, Leuven, AZ Sint-Jan Brugge-Oostende AV
- Életkor
- 18 év and over
- People
- 410 worldwide
- Run by
- Bochud Pierre-Yves
See details and how to joinNCT03828773 · EU 2024-517211-79-00 - 3. fázisTaking peopleIvosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
- Where
- Antwerp, Brussels, Ghent, Leuven, Liège, Yvoir
- Életkor
- 18 év and over
- People
- 227 worldwide
- Run by
- Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT07075016 - 2. fázisTaking peopleCHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
- Where
- Brussels, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Életkor
- 1 hónap to 18 év
- People
- 60 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06262438 · EU 2023-505000-27-01 - 3. fázisTaking peopleStudying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
- Where
- Brussels, Ghent, Leuven, Liège
- Életkor
- Up to 18 év
- People
- 170 worldwide
- Run by
- Vastra Gotaland Region
See details and how to joinNCT05477589 - 3. fázisTaking peopleNOPHO-DBH AML 2012 Protocol: Research study for treatment of children and adolescents with acute myeloid leukemia 0-18 years
- Where
- Brussels, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Életkor
- Up to 64 év
- People
- 730 worldwide
- Run by
- Vaestra Goetalandsregionen
See details and how to joinNCT01828489 · EU 2024-518254-16-00 - 2. fázisTaking peopleTreatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
- Where
- Brussels
- Életkor
- Up to 18 év
- People
- 89 worldwide
- Run by
- Associazione Italiana Ematologia Oncologia Pediatrica
See details and how to joinNCT04793919 · EU 2024-518669-83-00 - 2. fázisTaking peopleAllogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning
- Where
- Anderlecht, Antwerp, Brugge, Gent, Jette, Leuven, Roeselare, Sint-Lambrechts-Woluwe, Yvoir
- Életkor
- 18 év to 75 év
- People
- 114
- Run by
- University of Liege
See details and how to joinNCT03852407 · EU 2024-518568-11-00